Profil
Mr. Cyrille Carrière is a Chairman, Managing Director & Co-Founder at Lonvia Capital SASU.
He began his career in 1998 at Rothschild & Cie Gestion as a financial analyst.
In 2007, he joined Barclays Wealth Managers Paris as Vice-Chairman and became manager of the Euro zone mid-cap funds Barclays Small Cap and Barclays Euro Equity Small & Mid in 2008.
In 2012, he became Deputy Director of Equities & Convertibles Management at Groupama Asset Management.
He holds a Masters in Finance from ESCP and is a graduate of Paris 1 Sorbonne University in economics.
Aktive Positionen von Cyrille Carrière
| Unternehmen | Position | Beginn |
|---|---|---|
Lonvia Capital SASU
Lonvia Capital SASU Investment ManagersFinance Lonvia Capital invests in business models that are sustainable sources of value generation over the long-term. The firm looks for European small- and mid-cap companies with strong development potential given their positioning in buoyant markets and growth-oriented strategies based on product innovation, investment in human capital, the acquisition of new clients, and international expansion. They aim to support the development of these companies and facilitate the creation of long-term value for their shareholders. Lonvia Capital allocates 10% of its net profit to medical research, social inclusion, and environmental conservation. | Gründer | 01.01.2020 |
Ehemalige bekannte Positionen von Cyrille Carrière
| Unternehmen | Position | Ende |
|---|---|---|
Groupama Asset Management SA
Groupama Asset Management SA Investment ManagersFinance Groupama AM is an actively responsible, research-based manager which focuses on European equity and bond markets with specialist expertise in European large-caps and corporate investment grade bonds which aims to improve the risk/return ratio over the long term. For equities, the firm utilizes a bottom-up approach to select the most promising securities in line with market trends. Their fixed-income includes Eurozone or international sovereign debt, bonds indexed to euro or international inflation, investment grade credit management and aggregate asset management. Groupama AM offers short-term money market and bond funds tailored to the different cash needs of investors. An offer built to fully meet their main expectations on the asset class: low volatility, liquidity, regularity of performance. | Head-Equity Investments | 01.10.2020 |
Milleis Investissements SA
Milleis Investissements SA Investment ManagersFinance Barclays Wealth-France is an active, research-oriented investment manager also using passive management for some of their portfolios. The firm invests in global equity and debt across all market caps, with the bulk of their investments in French equity. Research is shared within the parent group. The firm follows a top-down, thematic investment approach for equity. Their investment process starts with the selection of investment themes through a macro-economic analysis (e.g. population aging, emergent industrial countries, mergers & acquisitions). The firm's theme-based strategic allocation is reviewed monthly. Stocks with absolute performance potential are selected through financial analysis. Portfolio managers confirm their convictions through company visits and regular contacts with management. The resulting portfolios do not benchmark any particular index. | Portfolio Manager-Aktien | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Groupama Asset Management SA
Groupama Asset Management SA Investment ManagersFinance Groupama AM is an actively responsible, research-based manager which focuses on European equity and bond markets with specialist expertise in European large-caps and corporate investment grade bonds which aims to improve the risk/return ratio over the long term. For equities, the firm utilizes a bottom-up approach to select the most promising securities in line with market trends. Their fixed-income includes Eurozone or international sovereign debt, bonds indexed to euro or international inflation, investment grade credit management and aggregate asset management. Groupama AM offers short-term money market and bond funds tailored to the different cash needs of investors. An offer built to fully meet their main expectations on the asset class: low volatility, liquidity, regularity of performance. | Finance |
Milleis Investissements SA
Milleis Investissements SA Investment ManagersFinance Barclays Wealth-France is an active, research-oriented investment manager also using passive management for some of their portfolios. The firm invests in global equity and debt across all market caps, with the bulk of their investments in French equity. Research is shared within the parent group. The firm follows a top-down, thematic investment approach for equity. Their investment process starts with the selection of investment themes through a macro-economic analysis (e.g. population aging, emergent industrial countries, mergers & acquisitions). The firm's theme-based strategic allocation is reviewed monthly. Stocks with absolute performance potential are selected through financial analysis. Portfolio managers confirm their convictions through company visits and regular contacts with management. The resulting portfolios do not benchmark any particular index. | Finance |
Lonvia Capital SASU
Lonvia Capital SASU Investment ManagersFinance Lonvia Capital invests in business models that are sustainable sources of value generation over the long-term. The firm looks for European small- and mid-cap companies with strong development potential given their positioning in buoyant markets and growth-oriented strategies based on product innovation, investment in human capital, the acquisition of new clients, and international expansion. They aim to support the development of these companies and facilitate the creation of long-term value for their shareholders. Lonvia Capital allocates 10% of its net profit to medical research, social inclusion, and environmental conservation. | Finance |
















